Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K, Cajanus A, Jääskeläinen O, Kontkanen A, Hartikainen P, Korhonen VE, Helisalmi S, Haapasalo A, Koivumaa-Honkanen H, Herukka SK, Remes AM, Solje E. Katisko K, et al. Among authors: jaaskelainen o. J Neurol. 2020 Jan;267(1):162-167. doi: 10.1007/s00415-019-09567-8. Epub 2019 Oct 8. J Neurol. 2020. PMID: 31595378 Free PMC article.
Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients.
Jääskeläinen O, Solje E, Hall A, Katisko K, Korhonen V, Tiainen M, Kangas AJ, Helisalmi S, Pikkarainen M, Koivisto A, Hartikainen P, Hiltunen M, Ala-Korpela M, Soininen H, Soininen P, Haapasalo A, Remes AM, Herukka SK. Jääskeläinen O, et al. J Alzheimers Dis. 2019;72(1):127-137. doi: 10.3233/JAD-190132. J Alzheimers Dis. 2019. PMID: 31561355 Free PMC article.
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.
Katisko K, Cajanus A, Huber N, Jääskeläinen O, Kokkola T, Kärkkäinen V, Rostalski H, Hartikainen P, Koivisto AM, Hannonen S, Lehtola JM, Korhonen VE, Helisalmi S, Koivumaa-Honkanen H, Herukka SK, Remes AM, Solje E, Haapasalo A. Katisko K, et al. Among authors: jaaskelainen o. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1305-1312. doi: 10.1136/jnnp-2021-326487. Epub 2021 Jun 29. J Neurol Neurosurg Psychiatry. 2021. PMID: 34187866
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
Katisko K, Solje E, Korhonen P, Jääskeläinen O, Loppi S, Hartikainen P, Koivisto AM, Kontkanen A, Korhonen VE, Helisalmi S, Malm T, Herukka SK, Remes AM, Haapasalo A. Katisko K, et al. Among authors: jaaskelainen o. J Neurol. 2020 Jan;267(1):76-86. doi: 10.1007/s00415-019-09552-1. Epub 2019 Sep 26. J Neurol. 2020. PMID: 31559531 Free PMC article.
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.
Niiranen M, Kontkanen A, Jääskeläinen O, Tertsunen HM, Selander T, Hartikainen P, Huber N, Solje E, Haapasalo A, Kokkola T, Lohioja T, Herukka SK, Simula S, Remes AM. Niiranen M, et al. Among authors: jaaskelainen o. Mult Scler Relat Disord. 2021 Nov;56:103280. doi: 10.1016/j.msard.2021.103280. Epub 2021 Sep 28. Mult Scler Relat Disord. 2021. PMID: 34627002
Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
Haapalinna F, Kokki M, Jääskeläinen O, Hallikainen M, Helisalmi S, Koivisto A, Kokki H, Paajanen T, Penttinen J, Pikkarainen M, Rautiainen M, Soininen H, Solje E, Remes AM, Herukka SK. Haapalinna F, et al. Among authors: jaaskelainen o. J Alzheimers Dis. 2018;62(1):165-174. doi: 10.3233/JAD-170534. J Alzheimers Dis. 2018. PMID: 29439329
17 results